Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Zimmermann

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
European Journal of Gastroenterology & Hepatology|November 15, 2019
Sarcopenia as prognostic factor for survival after orthotopic liver transplantationDaniel Pinto Dos Santos, Roman Kloeckner, Sandra Koch, et al.
Zeitschrift Fur Gastroenterologie|January 14, 2020
Urinary ethyl glucuronide (uEtG) as a marker for alcohol consumption in liver transplant candidates: a real-world cohortJohanna Vollmar, Franziska Stern, Karl Lackner, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 17, 2007
Efficacy of an escalating dose regimen of pegylated interferon alpha-2a plus ribavirin in the early phase of HCV reinfection after liver transplantationTim Zimmermann, Wulf O Böcher, Stefan Biesterfeld, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 7, 2012
Identification of RARRES1 as a core regulator in liver fibrosisAndreas Teufel, Diana Becker, Susanne N Weber, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 10, 2018
Progression of transthyretin (TTR) amyloidosis in donors and recipients after domino liver transplantation-a prospective single-center cohort studyJohanna Vollmar, Julia C Schmid, Maria Hoppe-Lotichius, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 19, 2012
No beneficial effect of all-trans retinoic acid in previous non-responder patients with chronic hepatitis C: the ATRACTION study, a phase II randomised trialMarcus Schuchmann, Jens M Kittner, Jörg F Schlaak, et al.
Oncotarget|February 1, 2018
Loss of organic cation transporter 3 (Oct3) leads to enhanced proliferation and hepatocarcinogenesisJohanna Vollmar, Anja Lautem, Ellen Closs, et al.
European Journal of Clinical Pharmacology|October 26, 2022
Oral mannitol for bowel preparation: a dose-finding phase II studyCristiano Spada, Giancarla Fiori, Peter Uebel, et al.
European Journal of Internal Medicine|June 4, 2018
Recipient liver function before liver transplantation influences post-transplantation survival in patients with HCCFriedrich Foerster, Jens Mittler, Felix Darstein, et al.
Journal of Clinical Medicine|July 29, 2020
Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant CentersCornelius Engelmann, Martina Sterneck, Karl Heinz Weiss, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
European Journal of Gastroenterology & Hepatology|November 15, 2019
Sarcopenia as prognostic factor for survival after orthotopic liver transplantationDaniel Pinto Dos Santos, Roman Kloeckner, Sandra Koch, et al.
Zeitschrift Fur Gastroenterologie|January 14, 2020
Urinary ethyl glucuronide (uEtG) as a marker for alcohol consumption in liver transplant candidates: a real-world cohortJohanna Vollmar, Franziska Stern, Karl Lackner, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 17, 2007
Efficacy of an escalating dose regimen of pegylated interferon alpha-2a plus ribavirin in the early phase of HCV reinfection after liver transplantationTim Zimmermann, Wulf O Böcher, Stefan Biesterfeld, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 7, 2012
Identification of RARRES1 as a core regulator in liver fibrosisAndreas Teufel, Diana Becker, Susanne N Weber, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 10, 2018
Progression of transthyretin (TTR) amyloidosis in donors and recipients after domino liver transplantation-a prospective single-center cohort studyJohanna Vollmar, Julia C Schmid, Maria Hoppe-Lotichius, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 19, 2012
No beneficial effect of all-trans retinoic acid in previous non-responder patients with chronic hepatitis C: the ATRACTION study, a phase II randomised trialMarcus Schuchmann, Jens M Kittner, Jörg F Schlaak, et al.
Oncotarget|February 1, 2018
Loss of organic cation transporter 3 (Oct3) leads to enhanced proliferation and hepatocarcinogenesisJohanna Vollmar, Anja Lautem, Ellen Closs, et al.
European Journal of Clinical Pharmacology|October 26, 2022
Oral mannitol for bowel preparation: a dose-finding phase II studyCristiano Spada, Giancarla Fiori, Peter Uebel, et al.
European Journal of Internal Medicine|June 4, 2018
Recipient liver function before liver transplantation influences post-transplantation survival in patients with HCCFriedrich Foerster, Jens Mittler, Felix Darstein, et al.
Journal of Clinical Medicine|July 29, 2020
Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant CentersCornelius Engelmann, Martina Sterneck, Karl Heinz Weiss, et al.
Pageof 9